Intravascular ultrasound (IVUS)-guided PCI was associated with lower long-term risk of cardiac death than an angiography-guided approach in patients with complex lesions, according to a single-center study published in JACC: Cardiovascular Interventions.
Cleveland Clinic this month announced it’s launching a Center for Clinical Artificial Intelligence (CCAI) dedicated to the development and application of AI in medicine.
French pharmaceutical startup Pharnext is leveraging AI and pleiotropy to develop new drug combinations and repurpose existing therapies, Fortune reported March 19.
Researchers can more accurately and comprehensively study the brain with a novel concept known as diattenuation imaging (DI)—a neuroimaging method that allows scientists to measure the polarization-dependent attenuation of light throughout different parts of the brain—according to a study published in Scientific Reports.
A remote monitoring protocol for heart failure patients with implantable electronic devices helped more of them stay out of the hospital over a one-year period than standard in-person visits, researchers reported at EHRA 2019.
When manually corrected by radiologists, an AI system for automatically detecting and segmenting colorectal metastases in the liver can improve interpretative efficiency, according to a study published online March 13 in Radiology: Artificial Intelligence.
Implementing digital breast tomosynthesis (DBT) leads to lower breast biopsy rates without having a negative impact on cancer detection, according to new findings published in Radiology.
Richard Kovacs, MD, left, assumes the role of American College of Cardiology president from C. Michael Valentine, MD, on March 18 at the ACC's scientific sessions in New Orleans (Photo by Todd Buchanan/ACC).
Richard Kovacs, MD, officially began his one-year stint as the president of the American College of Cardiology on March 18. The occasion was marked during a convocation ceremony on the final day of the ACC’s scientific sessions in New Orleans.
Carestream Health’s recent decision to sell its healthcare information systems business to Royal Philips has been greeted with a mostly positive reaction from the imaging industry, according to a new market report.
NEW ORLEANS — A new analysis considering not only a patient's first cardiovascular event—but the second, third and beyond—paints the REDUCE-IT trial in an even more positive light.
